Why Monopar Therapeutics, A Top 1% Biotech Stock, Just Surged Into A Breakout
- Posted on September 15, 2025
- By Yahoo News
- 1 Views
Why Monopar Therapeutics, A Top 1% Biotech Stock, Just Surged Into A Breakout
Monopar Therapeutics unveiled promising results Monday from three key studies, leading the top 1% biotech stock to break out of a cup base.
